- Global Pharma News & Resources

Ology Bioservices Appoints Vaccines and Biologics Manufacturing Industry Veteran, Brandon Brega, as Chief Operating Officer

Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today the appointment of vaccines and biologics manufacturing industry expert, Brandon Brega, to the position of Chief Operating Officer, effective immediately. In this newly created position, Brandon will lead manufacturing and operations at the company’s 183,000 square foot Department of Defense Advanced Development and Manufacturing (ADM) facility in Alachua, Florida.

This press release features multimedia. View the full release here:

Brandon Brega Chief Operating Officer Ology Bioservices, Inc. (Photo: Business Wire)

“With over 20 years of experience, including, plant management and technical operations, Brandon will apply his skills to further expand our capabilities in cGMP manufacturing and facility operations,” stated Peter H. Khoury, Ph.D., MBA, President and Chief Executive Officer of Ology Bioservices. “Brandon’s depth of expertise in vaccine and biological manufacturing, in particular, and his proven track record of achieving efficient operations, will be instrumental as we continue to enhance our operational performance and overall product quality.”

“Ology Bioservices is a dynamic and growing CDMO with a highly regarded reputation within both the governmental and commercial markets. The company’s state-of-the-art ADM facility was designed to take advantage of the latest Single Use Technology. I look forward to working with the team to bring online efficient and cGMP compliant manufacturing projects in parallel, in order to take maximum advantage of our multiproduct, multiuse open ballroom design.”

Prior to joining Ology Bioservices, Mr. Brega served in various positions at Merck & Co., most recently as Associate Vice President, Plant Management at the company’s Durham, North Carolina location – the largest vaccines-only facility in Merck’s network. Prior to joining Merck, Mr. Brega worked for a number of animal health manufacturers including Pfizer Inc., Wyeth Pharmaceuticals, Boehringer Ingelheim and Merial Ltd., leading operations and technical organizations in the production of vaccines, biologics and sterile injectables. He has broad base of experience with both drug substance and drug product manufacturing across both small and large molecules.

Mr. Brega holds both a Bachelor of Science in Biology and Master of Arts in Management from Doane University and earned a Masters Certification in Six Sigma and Lean Six Sigma Black Belt from Villanova University.

About Ology Bioservices, Inc.

Ology Bioservices is a privately-held, full-service Contract Development Manufacturing Organization (CDMO) serving both government and commercial clients, specializing in biologic drug substance manufacturing, from early stage through commercial product. The company has 183,000 square feet of manufacturing, process development and QA/QC space in its state-of-the-art, Department of Defense Advanced Development and Manufacturing Facility in Florida. The company’s infrastructure provides unique services to its clients, including full regulatory support from preclinical through licensure, clinical trial operational support and bioanalytical testing, as well as cGMP manufacturing up to Biosafety Level 3 (BSL3). Ology Bioservices has 20 years of experience developing and manufacturing drugs and biologics for the U.S. Government, with over $500M in government contracts awarded over that time. The team at Ology Bioservices has decades of experience manufacturing, developing and licensing vaccines and protein/antibody therapeutics.

View source version on

Editor Details

Last Updated: 23-Jan-2019